Sanford-Burnham, Takeda Form Obesity Partnership
By Catherine Shaffer
Wednesday, December 29, 2010
Just in time for the New Year's weight loss resolution season, Sanford-Burnham Medical Research Institute and Takeda Pharmaceutical Company Ltd., of Osaka, Japan, have teamed up to tackle the growing, worldwide problem of obesity. Under terms of a new partnership agreement, which also includes Orlando-based Florida Hospital, the parties will pursue a bottom-up strategy of identifying metabolic pathways and signatures to develop new, more personalized treatments for obesity and its associated conditions.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.